Delivery Order SPE2DB20D1100-SPE2DB24FZ35S
- Not listed
- This federal contract award is for the supply of 4,563,731,872 units of the pharmaceutical product Modafinil 200 mg tablet in 30-count packages to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., also known as Amerisourcebergen. The contract has a ceiling value of $1,410.18 and is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is February 22, 2024. This...
- This federal contract award, valued at $2,054.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,962,528 units of the medication Modafinil 100 mg tablet in 30-count packages. The contract has an ultimate completion date of April 21, 2025 and a firm fixed price pricing type. This award is not associated with a set-aside designation,...
- This federal contract award is for the delivery of 4,563,906,941 tablets of the prescription drug modafinil 200 mg, under a firm fixed-price delivery order from the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,067.47 and an ultimate completion date of March 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract (SPE2DB20D2104|SPE2DB24FT49C) worth $4,057.38 to provide 4,564,196,494 units of Modafinil 200 mg tablets. This order falls under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,530.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,026,421 modafinil 200 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This federal contract award, with ID SPE2DB22D2103|SPE2DB25FR9FH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,274 units of the drug modafinil 100 mg tablets, with a ceiling value of $7,724.51. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of May 8, 2025. There is no set-aside designation,...
- This federal contract award, identified as SPE2DB20D3505|SPE2DB25FU4K8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.74 delivery order contract is for the supply of 4,567,985,623 units of Modafinil 100 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp, the prime contractor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,027,366 units of modafinil 200 mg tablets. The firm-fixed-price delivery order, valued at $1,198.64, has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price pricing type and a ceiling value of $1,168.81. The contract is for the delivery of 4,563,949,331 modafinil 200 mg tablets in 90-count packages, with a period of performance through March 14, 2024....
- This federal contract award, with an ID of SPE2DB22D2206 and SPE2DB24FEX37, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,221,389 units of Modafinil 200 mg tablets in 90-count packages, with a ceiling value of $1,045.83. The contract has a firm fixed price and an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ35SDelivery Order
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ35S, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,143,365 units of the drug Modafinil 200 mg tablets in 90-count packages. The award has a ceiling value of $1,728.52 and an ultimate completion date of December 20, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with any set-aside requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/19/23 |